CP-96021 is a potent and orally available leukotriene D4 (LTD4 Ki=34 µM) / platelet activating factor (PAF Ki=37 µM) receptor antagonist. CP-96021 has antagonist capable of simultaneously targeting two different inflammatory mediators, LTD4 and PAF. CP-9